Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

SEC Form 4: Fickenscher James E was granted 20,800 shares and sold $6,614 worth of shares (6,013 units at $1.10), increasing direct ownership by 9% to 172,505 units to cover taxes

ByQuantisnow·Wall Street's wire, on your screen.
ZYNE· Zynerba Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.

SEC Form 4: Fickenscher James E was granted 20,800 shares and sold $6,614 worth of shares (6,013 units at $1.10), increasing direct ownership by 9% to 172,505 units to cover taxes | Quantisnow